Qiming U.s. Ventures Management, LLC
Qiming U.S. Ventures Management, LLC is a venture capital firm headquartered in Bellevue, Washington. Founded in 2017, the firm focuses primarily on investing in early-stage healthcare companies in the United States and Europe, leveraging its affiliation with China-based Qiming Venture Partners. With $515 million in assets under management, Qiming US offers both financial and operational support, connecting portfolio companies to cross-border resources and market opportunities. The team, which consists of experienced entrepreneurs, investors, and scientists, is committed to supporting innovative healthcare startups aiming to shape the future of the industry.
Investment Strategy
Qiming U.S. Ventures Management concentrates on early-stage investments in healthcare, targeting transformative medical and life science companies primarily in the United States and Europe. The firm leverages the broader Qiming network for market diligence, deal flow, and operational support, aiming to help its portfolio companies navigate ambitious growth paths and realize innovative breakthroughs. Its approach combines deep technical expertise, hands-on strategic guidance, and access to transpacific resources, aiming to foster entrepreneurship and provide value well beyond financial capital.
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
T TRML | TOURMALINE BIO INC | 50.22% | $11.9M | 741,691 | $25.82 | $15.99 | +$578.5K |
J JSPR | JASPER THERAPEUTICS INC | 21.83% | $5.2M | 928,964 | $28.30 | $5.55 | +$1.2M |
K KRRO | KORRO BIO INC | 19.47% | $4.6M | 368,085 | $47.93 | $12.49 | -$1.8M |
V VTYX | VENTYX BIOSCIENCES INC | 3.74% | $882.2K | 412,225 | $19.86 | $2.14 | +$408.1K |
H HLVX | HILLEVAX INC | 3.14% | $741.5K | 372,615 | $10.93 | $1.99 | +$201.2K |